Licence Changes & Product Updates

Branded generic of Fostair 100/6 pMDI launched for asthma and COPD

Branded generic of Fostair 100/6 pMDI launched for asthma and COPD

Luforbec 100/6 pressurised metered dose inhaler (pMDI)...

New warning for AstraZeneca COVID-19 vaccine

New warning for AstraZeneca COVID-19 vaccine

A warning about Guillain-Barré syndrome has been added...

Moderna COVID-19 vaccine approved in adolescents

Moderna COVID-19 vaccine approved in adolescents

The Moderna COVID-19 vaccine, now known as Spikevax,...

Irbesartan batches recalled over contamination

Irbesartan batches recalled over contamination

Batches of some irbesartan-containing products are...

Second SGLT2 inhibitor approved for heart failure

Second SGLT2 inhibitor approved for heart failure

Clinicians now have a choice of SGLT2 inhibitors to...

SGLT2 inhibitor licensed to treat chronic kidney disease

SGLT2 inhibitor licensed to treat chronic kidney disease

Forxiga (dapagliflozin) can now be prescribed to treat...

New contraindication for AstraZeneca COVID-19 vaccine

New contraindication for AstraZeneca COVID-19 vaccine

The AstraZeneca COVID-19 vaccine, now known as Vaxzevria,...

Chloramphenicol eye drops safe for under 2s, says MHRA

Chloramphenicol eye drops safe for under 2s, says MHRA

The balance between the benefits and risks of chloramphenicol...

Myocarditis warning for Pfizer and Moderna COVID-19 vaccines

Myocarditis warning for Pfizer and Moderna COVID-19 vaccines

Prescribing information for the Pfizer/BioNTech and...

MIMS drug shortages tracker updated with latest supply issues

MIMS drug shortages tracker updated with latest supply issues

Supply issues have been reported in the past week for...